DekaBank Deutsche Girozentrale’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,064
Closed -$513K 1426
2021
Q3
$513K Sell
2,064
-223
-10% -$63.7K ﹤0.01% 1044
2021
Q2
$882K Hold
2,287
﹤0.01% 943
2021
Q1
$850K Buy
2,287
+223
+11% +$110K ﹤0.01% 935
2020
Q4
$1.17M Sell
2,064
-100
-5% -$63.4K ﹤0.01% 820
2020
Q3
$1.53M Buy
+2,164
New +$1.69M 0.01% 649
2020
Q1
Sell
-93
Closed -$106K 1065
2019
Q4
$106K Buy
+93
New +$101K ﹤0.01% 1027

Other funds holding BLUE

DekaBank Deutsche Girozentrale's BLUE Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 2,064 shares — an estimated $513K sold.

DekaBank Deutsche Girozentrale first reported a position in BLUE in Q4 2019 and held it in 6 quarters. The position peaked at $1.53M in Q3 2020. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 2,064 bluebird bio shares in Q4 2021, an estimated $513K.
  • DekaBank Deutsche Girozentrale first reported a position in bluebird bio in Q4 2019 and held it in 6 quarters.
  • DekaBank Deutsche Girozentrale's bluebird bio position peaked at $1.53M in Q3 2020.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.